01:19 PM EST, 11/03/2025 (MT Newswires) -- WELL Health Technologies ( WHTCF ) announced a $62 million Series B financing and private round for Wellstar, led by institutional investors, Mawer, Edgepoint and Picton. Wellstar is the healthcare SaaS platform within WELL, last disclosed generating +$70 million sales (80-90% recurring), 25% adj. EBITDA margins and growing at +20%, Stifel Canada notes.

The $62 million financing, follows last December's $50.4 million Series A round, and provides substantial growth capital, ahead of an expected spin-out/IPO next year, analyst Justin Keywood writes.

Wellstar is acquisitive with a substantial roll-up opportunity for healthcare software assets in Canada, as well as organic growth strength (mid-teens to 20%+). The strong institutional support also highlights value that resides within WELL Healthcare, including the Canadian clinic network (#1 market share), although overshadowed by streamlining activities underway but highlighting additional value to unlock.

Well Health ( WHTCF ) is rated Buy, with a $9 price target.

Price: 5.18, Change: -0.08, Percent Change: -1.43